Cardioprotective effects of sour cherry seed extract (SCSE) on the hypercholesterolemic rabbit heart

Current Pharmaceutical Design

Volumn 19, Issue 39, 2013, Pages 6896-6905

  Juhasz, Bela ^a   Kertész, Attila ^a   Balla, Jozsef ^b,c   Balla, Gyorgy ^a,b   Szabo, Zoltán ^c   Bombicz, Mariann ^a   Priksz, Daniel ^a   Gesztelyi, Rudolf ^a   Varga, Balazs ^a   Haines, David D ^a   Tosaki, Arpad ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Atherosclerosis; Ischaemia reperfusion; Isolated rabbit heart; Sour cherry seed extract

Indexed keywords

CHOLESTEROL; CYTOCHROME C OXIDASE; HEME OXYGENASE 1; PLANT EXTRACT; SOUR CHERRY SEED EXTRACT; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA FLOW; AORTA PRESSURE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR PARAMETERS; CHOLESTEROL DIET; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE; HEART PROTECTION; HEART RATE; HYPERCHOLESTEROLEMIA; INFLAMMATION; MALE; NONHUMAN; OXIDATIVE STRESS; PEAK ATRIAL VELOCITY; PEAK EARLY DIASTOLIC VELOCITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SOUR CHERRY; STAINING; TISSUE DOPPLER IMAGING; ULTRASOUND SCANNER; WESTERN BLOTTING;

ANIMALS; CARDIOTONIC AGENTS; CHOLESTEROL; HYPERCHOLESTEROLEMIA; MALE; PLANT EXTRACTS; PRUNUS; RABBITS; SEEDS;

EID: 84884540382     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161281939131127120517     Document Type: Article

References (44)

1. McClintock D, Gordon LB, Djabali K. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. Proc Natl Acad Sci USA 2006; 103: 2154-9.
2. Haines DD, Lekli I, Teissier P, Bak I, Tosaki A. Role of haeme oxygenase-1 in resolution of oxidative stress-related pathologies: focus on cardiovascular, lung, neurological and kidney disorders. Acta Physiol (Oxf) 2012; 204: 487-501.
3. Hussain MM. A proposed model for the assembly of chylomicrons. Atherosclerosis 2000; 148: 1-15.
4. Nakano T, Nakajima K, Niimi M, et al. Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases. Clin Chim Acta 2008; 390: 38-43.
5. Toth PP. Cardiology patient page. The "good cholesterol": highdensity lipoprotein. Circulation 2005; 111: e89-91.
6. Israili ZH, Lyoussi B, Hernandez-Hernandez R, Velasco M. Metabolic syndrome: treatment of hypertensive patients. Am J Ther 2007; 14: 386-402.
7. Liebson PR, Amsterdam EA. Prevention of coronary heart disease. Part I. Primary prevention. Dis Mon 1999; 45: 497-571.
8. Safeer RS, Cornell MO. The emerging role of HDL cholesterol. Is it time to focus more energy on raising high-density lipoprotein levels? Postgrad Med 2000; 108: 87-90, 93-8.
9. Hausenloy DJ, Yellon DM. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. Heart 2008; 94: 706-14.
10. Thijssen MA, Mensink RP. Fatty acids and atherosclerotic risk. Handb Exp Pharmacol 2005: 165-94.
11. Masson D, Deckert V, Gautier T, et al. Worsening of diet-induced atherosclerosis in a new model of transgenic rabbit expressing the human plasma phospholipid transfer protein. Arterioscler Thromb Vasc Biol 2011; 31: 766-74.
12. Gysembergh A, Kloner RA, Przyklenk K. Pretreatment with the gap junction uncoupler heptanol does not limit infarct size in rabbit heart. Cardiovasc Pathol 2001; 10: 13-7.
13. Przyklenk K, Li G, Simkhovich BZ, Kloner RA. Mechanisms of myocardial ischemic preconditioning are age related: PKC-epsilon does not play a requisite role in old rabbits. J Appl Physiol 2003; 95: 2563-9.
14. Szabo ME, Gallyas E, Bak I, et al. Heme oxygenase-1-related carbon monoxide and flavonoids in ischemic/reperfused rat retina. Invest Ophthalmol Vis Sci 2004; 45: 3727-32.
15. Bak I, Czompa A, Csepanyi E, et al. Evaluation of systemic and dermal toxicity and dermal photoprotection by sour cherry kernels. Phytother Res 2011; 25: 1714-20.
16. Bartekova M, Carnicka S, Pancza D, Ondrejcakova M, Breier A, Ravingerova T. Acute treatment with polyphenol quercetin improves postischemic recovery of isolated perfused rat hearts after global ischemia. Can J Physiol Pharmacol 2010; 88: 465-71.
17. Das S, Mukherjee S, Lekli I, et al. Tocotrienols confer resistance to ischemia in hypercholesterolemic hearts: insight with genomics. Mol Cell Biochem 2012; 360: 35-45.
18. Neely JR, Liebermeister H, Battersby EJ, Morgan HE. Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol 1967; 212: 804-14.
19. Juhasz B, Der P, Turoczi T, Bacskay I, Varga E, Tosaki A. Preconditioning in intact and previously diseased myocardium: laboratory or clinical dilemma? Antioxid Redox Signal 2004; 6: 325-33.
20. Schultz JE, Yao Z, Cavero I, Gross GJ. Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart. Am J Physiol 1997; 272: H2607-15.
21. Dickson EW, Blehar DJ, Carraway RE, Heard SO, Steinberg G, Przyklenk K. Naloxone blocks transferred preconditioning in isolated rabbit hearts. J Mol Cell Cardiol 2001; 33: 1751-6.
22. Csonka C, Kupai K, Kocsis GF, et al. Measurement of myocardial infarct size in preclinical studies. J Pharmacol Toxicol Methods 2010; 61: 163-70.
23. Salloum FN, Takenoshita Y, Ockaili RA, et al. Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits. J Mol Cell Cardiol 2007; 42: 453-8.
24. Libby P. Managing the risk of atherosclerosis: the role of highdensity lipoprotein. Am J Cardiol 2001; 88: 3N-8N.
25. Fahy E, Subramaniam S, Brown HA, et al. A comprehensive classification system for lipids. J Lipid Res 2005; 46: 839-61.
26. Hanukoglu I. Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis. J Steroid Biochem Mol Biol 1992; 43: 779-804.
27. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010; 30: 1282-92.
28. Guerin M. Reverse cholesterol transport in familial hypercholesterolemia. Curr Opin Lipidol 2012; 23: 377-85.
29. Rana JS, Boekholdt SM, Kastelein JJ, Shah PK. The role of non-HDL cholesterol in risk stratification for coronary artery disease. Curr Atheroscler Rep 2012; 14: 130-4.
30. Durrington P. Dyslipidaemia. Lancet 2003; 362: 717-31.
31. Bhatnagar D, Soran H, Durrington PN. Hypercholesterolaemia and its management. BMJ 2008; 337: a993.
32. Ong WY, Tan B, Pan N, et al. Increased iron staining in the cerebral cortex of cholesterol fed rabbits. Mech Ageing Dev 2004; 125: 305-13.
33. Ravingerova T, Adameova A, Kelly T, et al. Changes in PPAR gene expression and myocardial tolerance to ischaemia: relevance to pleiotropic effects of statins. Can J Physiol Pharmacol 2009; 87: 1028-36.
34. Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG. Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication. J Clin Endocrinol Metab 2012.
35. Le Grand B, Vie B, Faure P, Degryse AD, Mouillard P, John GW. Increased resistance to ischaemic injury in the isolated perfused atherosclerotic heart of the cholesterol-fed rabbit. Cardiovasc Res 1995; 30: 689-96.
36. Rubinstein J, Pelosi A, Vedre A, Kotaru P, Abela GS. Hypercholesterolemia and myocardial function evaluated via tissue doppler imaging. Cardiovasc Ultrasound 2009; 7: 56.
37. Li T, Matozel M, Boehme S, et al. Overexpression of cholesterol 7alpha-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis. Hepatology 2011; 53: 996-1006.
38. Amo Y, Masuzawa M, Hamada Y, Katsuoka K. Expression of vascular endothelial growth factor in a human hemangiosarcoma cell line (ISO-HAS). Arch Dermatol Res 2001; 293: 296-301.
39. Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007; 19: 2003-12.
40. Urbich C, Dimmeler S. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int 2005; 67: 1672-6.
41. Csont T, Bereczki E, Bencsik P, et al. Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice. Cardiovasc Res 2007; 76: 100-9.
42. Kocsis GF, Csont T, Varga-Orvos Z, Puskas LG, Murlasits Z, Ferdinandy P. Expression of genes related to oxidative/nitrosative stress in mouse hearts: effect of preconditioning and cholesterol diet. Med Sci Monit 2010; 16: BR32-9.
43. Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 2007; 50: 636-42.
44. Schulz R, Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res 1995; 30: 432-9.